Comparison of BNT162b2 (Pfizer-BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients

Kidney Int. 2021 Sep;100(3):697-698. doi: 10.1016/j.kint.2021.07.004. Epub 2021 Jul 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Immunogenicity, Vaccine
  • RNA, Messenger / genetics
  • Renal Dialysis / adverse effects
  • SARS-CoV-2*

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • BNT162 Vaccine